Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nuance Biotech Inc.

www.nuancebiotech.com

Latest From Nuance Biotech Inc.

Finance Watch: Global Ventures Step Into The Spotlight As The US Takes A Breather

Private Company Edition: I-Mab's $220m Series C round continued the trend of big investments in companies focused on or headquartered in China. Also, Shanghai-based Nuance brought in a combined $35m and European firms dominated recent small financings as US VC deals took a summer break.

Financing StartUps and SMEs

Deal Watch Asia Focus: Merck Partners With Alibaba For Entry To Digital Health In China

China’s Everest licenses global rights to Novartis FGFR4 inhibitor, while Altogen and Lynkogen partner in NASH and metabolic disease.

Deals Commercial
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Cancer
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Parent & Subsidiaries
  • Nuance Biotech Inc.
  • Senior Management
  • Mark G Lotter, CEO
    Zhou Xiaohui, MD, VP, Medical & Regulatory
    Justin Ni, CTO
  • Contact Info
  • Nuance Biotech Inc.
    Phone: 21 32035318
    8th floor, No.71 West Suzhou Rd.
    Jingan District
    Shanghai,
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register